These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 23178439

  • 1. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
    Fang Y, Chen Y, Yu L, Zheng C, Qi Y, Li Z, Yang Z, Zhang Y, Shi T, Luo J, Liu M.
    J Natl Cancer Inst; 2013 Jan 02; 105(1):47-58. PubMed ID: 23178439
    [Abstract] [Full Text] [Related]

  • 2. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
    Sin S, Bonin F, Petit V, Meseure D, Lallemand F, Bièche I, Bellahcène A, Castronovo V, de Wever O, Gespach C, Lidereau R, Driouch K.
    J Natl Cancer Inst; 2011 Sep 07; 103(17):1323-37. PubMed ID: 21832234
    [Abstract] [Full Text] [Related]

  • 3. EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung.
    Park CY, Son JY, Jin CH, Nam JS, Kim DK, Sheen YY.
    Eur J Cancer; 2011 Nov 07; 47(17):2642-53. PubMed ID: 21852112
    [Abstract] [Full Text] [Related]

  • 4. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG, Huang H, Chen SM, Chen Y, Xin XL, Lin LP, Ding J, Liu H, Meng LH.
    Breast Cancer Res Treat; 2011 Nov 07; 130(1):85-96. PubMed ID: 21181437
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, Muiru GT, Murphy A, Higgins LS, Chakravarty S, Wong DH.
    Mol Pharmacol; 2007 Jul 07; 72(1):152-61. PubMed ID: 17400764
    [Abstract] [Full Text] [Related]

  • 6. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY, Min KN, Son JY, Park SY, Nam JS, Kim DK, Sheen YY.
    Cancer Lett; 2014 Aug 28; 351(1):72-80. PubMed ID: 24887560
    [Abstract] [Full Text] [Related]

  • 7. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
    Zhong Z, Carroll KD, Policarpio D, Osborn C, Gregory M, Bassi R, Jimenez X, Prewett M, Liebisch G, Persaud K, Burtrum D, Wang S, Surguladze D, Ng S, Griffith H, Balderes P, Doody J, Schwartz JD, Youssoufian H, Rowinsky EK, Ludwig DL, Witte L, Zhu Z, Wu Y.
    Clin Cancer Res; 2010 Feb 15; 16(4):1191-205. PubMed ID: 20145179
    [Abstract] [Full Text] [Related]

  • 8. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
    Wang J, Zhang L, Chen G, Zhang J, Li Z, Lu W, Liu M, Pang X.
    Breast Cancer Res Treat; 2014 Nov 15; 148(2):279-89. PubMed ID: 25301089
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β signaling pathway.
    Zheng C, Fang Y, Tong W, Li G, Wu H, Zhou W, Lin Q, Yang F, Yang Z, Wang P, Peng Y, Pang X, Yi Z, Luo J, Liu M, Chen Y.
    J Med Chem; 2014 Feb 13; 57(3):600-12. PubMed ID: 24417479
    [Abstract] [Full Text] [Related]

  • 10. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
    Kawajiri H, Yashiro M, Shinto O, Nakamura K, Tendo M, Takemura S, Node M, Hamashima Y, Kajimoto T, Sawada T, Ohira M, Hirakawa K.
    Clin Cancer Res; 2008 May 01; 14(9):2850-60. PubMed ID: 18451253
    [Abstract] [Full Text] [Related]

  • 11. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M.
    Cancer Res; 2004 Nov 01; 64(21):7954-61. PubMed ID: 15520202
    [Abstract] [Full Text] [Related]

  • 12. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
    Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, Inamoto T, Takahara S, Itoh Y, Otsuki Y, Katsuoka Y, Miyazono K, Horie S.
    J Natl Cancer Inst; 2005 Dec 07; 97(23):1734-46. PubMed ID: 16333029
    [Abstract] [Full Text] [Related]

  • 13. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
    Tanaka S, Pero SC, Taguchi K, Shimada M, Mori M, Krag DN, Arii S.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):491-8. PubMed ID: 16595785
    [Abstract] [Full Text] [Related]

  • 14. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 15. The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
    Zhao H, Cui K, Nie F, Wang L, Brandl MB, Jin G, Li F, Mao Y, Xue Z, Rodriguez A, Chang J, Wong ST.
    Breast Cancer Res Treat; 2012 Jan 15; 131(2):425-36. PubMed ID: 21394501
    [Abstract] [Full Text] [Related]

  • 16. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.
    Carcinogenesis; 2013 Apr 15; 34(4):874-84. PubMed ID: 23275155
    [Abstract] [Full Text] [Related]

  • 17. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
    Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY, Wang WJ, Li QQ, Chen Q, Xu ZD, Liu XP.
    Breast Cancer Res Treat; 2010 Sep 15; 123(2):375-86. PubMed ID: 19946739
    [Abstract] [Full Text] [Related]

  • 18. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
    Park SJ, Choi YS, Lee S, Lee YJ, Hong S, Han S, Kim BC.
    Cancer Lett; 2016 Oct 28; 381(2):314-22. PubMed ID: 27543359
    [Abstract] [Full Text] [Related]

  • 19. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.
    Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771
    [Abstract] [Full Text] [Related]

  • 20. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M, Kleber S, Röhrich M, Timke C, Han N, Tuettenberg J, Martin-Villalba A, Debus J, Peschke P, Wirkner U, Lahn M, Huber PE.
    Cancer Res; 2011 Dec 01; 71(23):7155-67. PubMed ID: 22006998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.